A multicentre randomized-controlled trial of inhaled milrinone in high-risk cardiac surgical patients
André Denault(Montreal Heart Institute), Jean Lambert(Montreal Heart Institute), Mahsa Elmi-Sarabi(Montreal Heart Institute), Anne Quynh-Nhu Nguyen(Université de Montréal), France Varin(Université de Montréal), Yanfen Shi(Montreal Heart Institute), Sylvie Lévesque, Jean‐Claude Tardif(Montreal Heart Institute), Barry A. Finegan(University of Alberta), Annik Fortier(Montreal Heart Institute), Paul Gavra(Université de Montréal), Louis P. Perrault(Winthrop-University Hospital), François Haddad(Cardiovascular Institute of the South), Jean S. Bussières(Institut universitaire de cardiologie et de pneumologie de Québec), Ramiro Arellano(Queen's University)
Cited by 88
Related Papers
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
|New England Journal of Medicine|2015|2.3k
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2012|2k
Amiodarone to Prevent Recurrence of Atrial Fibrillation
|New England Journal of Medicine|2000|1.2k